BRIEF published on 08/05/2024 at 16:05, 2 years 1 month ago Vascular Therapies Completes Enrollment in Phase III ACCESS 2 Study for Sirogen Clinical Trial Vascular Access Sirolimus AV Fistula Hemodialysis
BRIEF published on 08/05/2024 at 16:05, 2 years 1 month ago Vascular Therapies achève son recrutement dans l'étude de phase III ACCESS 2 pour Sirogen Essai Clinique Sirolimus Accès Vasculaire Fistule AV Hémodialyse
BRIEF published on 08/05/2024 at 16:05, 2 years 1 month ago REDi Announces Integration With Q2's Digital Banking Platform Digital Transformation Fraud Prevention Financial Technology Customer Engagement Banking Integration
BRIEF published on 08/05/2024 at 16:05, 2 years 1 month ago REDi annonce son intégration avec la plateforme bancaire numérique du deuxième trimestre Transformation Numérique Technologie Financière L'engagement Des Clients Prévention De La Fraude Intégration Bancaire
BRIEF published on 08/05/2024 at 16:05, 2 years 1 month ago ChainFEST, the World's Largest Celebration of Chain Restaurants, Sets New York City Debut ChainFEST New York Debut Gourmet Chain Dishes VIP Experiences Cash App Pre-sale
BRIEF published on 08/05/2024 at 16:05, 2 years 1 month ago ChainFEST, la plus grande célébration des chaînes de restaurants au monde, fait ses débuts à New York ChaîneFEST Débuts À New York Plats De Chaîne Gastronomiques Expériences VIP Prévente De L'application Cash
BRIEF published on 08/05/2024 at 16:05, 2 years 1 month ago Innovative Breakthroughs in Aesthetic Medicine: Dr. Maria Fedchuk’s Contributions Aesthetic Medicine Innovative Treatments FDA Approved Exosomal Liquid Laser Dr. Maria Fedchuk
BRIEF published on 08/05/2024 at 16:05, 2 years 1 month ago Percées innovantes en médecine esthétique : contributions du Dr Maria Fedchuk Médecine Esthétique Traitements Innovants Approuvé Par La FDA Laser Liquide Exosomal Dr Maria Fedchuk
BRIEF published on 08/05/2024 at 16:00, 2 years 1 month ago Spectral Capital Corporation Launches Quantum Bridge Program Innovation Technology Startups Quantum Computing Spectral Capital
BRIEF published on 08/05/2024 at 16:00, 2 years 1 month ago Spectral Capital Corporation lance le programme Quantum Bridge Technologie Innovation Startups L'informatique Quantique Capitale Spectrale
Published on 09/11/2026 at 04:00, 7 hours 19 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 54 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 59 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours 19 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 1 hour 4 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 59 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 2 hours 14 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 2 hours 19 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 4 hours 19 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 4 hours 19 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours 19 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 49 minutes ago Availability of the 2026 Interim Financial Report
